Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Atezolizumab Monotherapy or Combined Therapy with Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Alimohammadi M, Faramarzi F, Mafi A, Mousavi T, Rahimi A, Mirzaei H, Asemi Z. Alimohammadi M, et al. Among authors: faramarzi f. Curr Pharm Des. 2023;29(31):2461-2476. doi: 10.2174/0113816128270102231016110637. Curr Pharm Des. 2023. PMID: 37921135
Effects of coenzyme Q10 supplementation on inflammation, angiogenesis, and oxidative stress in breast cancer patients: a systematic review and meta-analysis of randomized controlled- trials.
Alimohammadi M, Rahimi A, Faramarzi F, Golpour M, Jafari-Shakib R, Alizadeh-Navaei R, Rafiei A. Alimohammadi M, et al. Among authors: faramarzi f. Inflammopharmacology. 2021 Jun;29(3):579-593. doi: 10.1007/s10787-021-00817-8. Epub 2021 May 18. Inflammopharmacology. 2021. PMID: 34008150
The effect of immunomodulatory properties of naringenin on the inhibition of inflammation and oxidative stress in autoimmune disease models: a systematic review and meta-analysis of preclinical evidence.
Alimohammadi M, Mohammad RN, Rahimi A, Faramarzi F, Alizadeh-Navaei R, Rafiei A. Alimohammadi M, et al. Among authors: faramarzi f. Inflamm Res. 2022 Nov;71(10-11):1127-1142. doi: 10.1007/s00011-022-01599-7. Epub 2022 Jul 8. Inflamm Res. 2022. PMID: 35804246 Review.
Immunogenicity of COVID-19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta-analysis.
Al-Haideri M, Mohammad TAM, Darvishzadehdeldari S, Karbasi Z, Alimohammadi M, Faramarzi F, Khorasani S, Rasouli A, Tahmasebi S, Darvishi M, Akhavan-Sigari R. Al-Haideri M, et al. Among authors: faramarzi f. Int J Rheum Dis. 2023 Jul;26(7):1227-1234. doi: 10.1111/1756-185X.14713. Epub 2023 Jun 12. Int J Rheum Dis. 2023. PMID: 37309305 Review.
The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence.
Al-Haideri MT, Mannani R, Kaboli R, Gharebakhshi F, Darvishzadehdeldari S, Tahmasebi S, Faramarzi F, Cotrina-Aliaga JC, Khorasani S, Alimohammadi M, Darvishi M, Akhavan-Sigari R. Al-Haideri MT, et al. Among authors: faramarzi f. Transpl Immunol. 2023 Aug;79:101858. doi: 10.1016/j.trim.2023.101858. Epub 2023 May 24. Transpl Immunol. 2023. PMID: 37236514 Free PMC article. Review.
43 results